Eicosapentaenoic acid and docosahexaenoic acid containing supplements modulate risk factors for cardiovascular disease: a meta-analysis of randomised placebo-control human clinical trials.

Suhad S AbuMweisS JewR TayyemL Agraib

Published in: Journal of human nutrition and dietetics : the official journal of the British Dietetic Association (2017)

The lipid-lowering, hypotensive, anti-arrhythmic and anti-inflammatory actions of EPA and DHA supplements were confirmed in this analysis of randomised placebo-control blinded clinical trials.

Keyphrases

clinical trial
double blind
placebo controlled
phase iii
cardiovascular disease
open label
phase ii
study protocol
fatty acid
anti inflammatory
endothelial cells
randomized controlled trial
type diabetes
induced pluripotent stem cells
coronary artery disease